BAY 41-2272
Tocris Bioscience, part of Bio-Techne | Catalog # 4430
Soluble guanylyl cyclase (sGC) activator
Key Product Details
Description
Soluble guanylyl cyclase (sGC) activator
Product Description
BAY 41-2272 is an activator of soluble guanylyl cyclase (sGC); acts at a nitric oxide (NO)-independent regulatory site in the sGC α1 subunit. Inhibits platelet aggregation (IC50 = 36 nM) and phenylephrine-induced contractions of rabbit aorta (IC50 = 0.30 μM). Also reduces vascular smooth muscle growth through cAMP- and cGMP-dependent PKA and PKG pathways.Product Specifications
Molecular Weight
360.39
Formula
C20H17FN6
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
5-Cyclopropyl-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-4-pyrimidinamine
CAS Number
256376-24-6
PubChem ID
9798973
InChI Key
ATOAHNRJAXSBOR-UHFFFAOYSA-N
SMILES
FC(C=CC=C3)=C3CN2N=C(C4=NC=C(C5CC5)C(N)=N4)C1=CC=CN=C12
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 36.04 | 100 |
Preparing Stock Solutions
for BAY 41-2272
The following data is based on the product molecular weight 360.39
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.77 mL | 13.87 mL | 27.75 mL |
| 5 mM | 0.55 mL | 2.77 mL | 5.55 mL |
| 10 mM | 0.28 mL | 1.39 mL | 2.77 mL |
| 50 mM | 0.06 mL | 0.28 mL | 0.55 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Joshi The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. J.Pharmacol.Exp.Ther. 2011 PMID: 21825001
- Mittendorf Discovery of Riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 2009 PMID: 19263460
- Stasch NO-independent regulatory site on soluble guanylate cyclase. Nature 2010 PMID: 11242081
Product Specific Notices for BAY 41-2272
For research use only
Loading...
Loading...